FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103550 [Registered on: 10/02/2026] Trial Registered Prospectively
Last Modified On: 09/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   A study of the clinical presentation, radiological findings, and causes of community acquired pneumonia at a tertiary care hospital  
Scientific Title of Study   Clinical, Radiological and Etiological Profile of Community-Acquired Pneumonia in a Tertiary Care Center 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gurinder Mohan 
Designation  Professor and HOD 
Affiliation  SGRDIMSR, Amritsar 
Address  Department of medicine, unit 1 , Sri guru ram das institute of medical sciences and research amritsar punjab

Amritsar
PUNJAB
143501
India 
Phone  9815341556  
Fax    
Email  gmohan1.med@sgrdimsr.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gurinder Mohan 
Designation  Professor and HOD 
Affiliation  Sri guru ram das institute of medical sciences and research amritsar punjab  
Address  Department of medicine, sri guru ram das institute of medical sciences and research amritsar punjab

Amritsar
PUNJAB
143501
India 
Phone  9815341556  
Fax    
Email  gmohan1.med@sgrdimsr.in  
 
Details of Contact Person
Public Query
 
Name  Jashanjeet Singh 
Designation  Junior Resident 
Affiliation  Sri Guru Ram Das Institute of Medical Sciences and Research , Sri Amritsar , Punjab , India 143001 
Address  Sri guru ram das institute of medical sciences and research amritsar punjab india

Amritsar
PUNJAB
143501
India 
Phone  9646171497  
Fax    
Email  mail.jashan.jeet@gmail.com  
 
Source of Monetary or Material Support  
Department of Medicine Sri Guru Ram Dass Institute of Medical Sciences and Research, Vallah, Amritsar, Punjab, India, 143001 
 
Primary Sponsor  
Name  Department of Medicine  
Address  Sri Guru Ram Dass Institute of Medical Sciences and Research Vallah Amritsar,Punjab,India,143001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jashanjeet Singh  Department of Medicine   Department of medicine Sri Guru Ram Das Institute of Medical Sciences and Research Vallah Amritsar, Punjab, India, 143001
Amritsar
PUNJAB 
9646171497

singhjashanjeet2812@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J09-J18||Influenza and pneumonia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Adult patients (18 years)
2. Patients with clinical features suggestive of CAP (fever, cough with or without expectoration, pleuritic chest pain, dyspnea and altered sensorium.) and with Radiological evidence of pneumonia 
 
ExclusionCriteria 
Details  1. Patients with hospital-acquired pneumonia.
2. Patients with ventilator-associated pneumonia.
3. Patients with healthcare-associated pneumonia.
3. Patients with active Pulmonary Tuberculosis.
4. Patients who have been hospitalized or institutionalized within the previous 90  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To determine most common clinical presentation , radiological findings, and causes of Community Acquired Pneumonia and initiating appropriate empirical antibiotic therapy, reducing complications, and improving patient outcomes.   Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
To analyze clinical outcomes such as duration of hospital stay, need for ICU admission, complications.  Baseline 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Community-acquired pneumonia (CAP) is a major global cause of illness and death, especially in developing countries. It presents with symptoms such as fever, productive cough, breathlessness, chest pain, and systemic features, with severity ranging from mild disease to life-threatening illness. Radiologically, chest X-ray commonly shows lobar consolidation, bronchopneumonia, or interstitial infiltrates, while HRCT is useful in atypical or complicated cases. Etiologically, Streptococcus pneumoniae is the most common pathogen, though atypical bacteria, viral agents, gram-negative bacilli, and Staphylococcus aureus are increasingly recognized, particularly in severe cases. Clinical, radiological, and etiological profiling in tertiary care settings is essential for accurate diagnosis, appropriate empirical therapy, and improved patient outcomes. 
Close